Mechanistically, PFD significantly downregulates TGF-β production in the RCC mouse model, thus mitigating TGF-β-mediated EMT and immunosuppressive MDSC infiltration into the TME. The gene discussed is TGFB1; the disease is renal cell carcinoma.